Education
About Us
Working with TipRanks
Follow Us
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
0455 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.27
Previous CloseN/A
Volume4.00K
Average Volume (3M)77.20K
Market Cap
HK$374.11M
Enterprise ValueHK$671.54M
Total Cash (Recent Filing)HK$103.77M
Total Debt (Recent Filing)HK$98.81M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Nov 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 13, 2024Dividend Yield2.99%
Share Statistics
EPS (TTM)-0.03
Shares Outstanding2,150,041,700
10 Day Avg. Volume158,800
30 Day Avg. Volume77,200
Financial Highlights & Ratios
PEG Ratio-2.61
Price to Book (P/B)0.66
Price to Sales (P/S)0.00
P/FCF Ratio-35.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tianda Pharmaceuticals Ltd. News
PremiumCompany Announcements
Tianda Pharmaceuticals Announces Board Changes to Enhance Governance
PremiumCompany Announcements
Tianda Pharmaceuticals Announces Board Restructuring
PremiumCompany Announcements
Tianda Pharmaceuticals Enhances Governance with New Nomination Committee
PremiumCompany Announcements
Tianda Pharmaceuticals Secures Unanimous Approval at AGMPremiumCompany Announcements
Tianda Pharmaceuticals Announces AGM and Share Repurchase Plan
PremiumCompany Announcements
Tianda Pharmaceuticals Issues Profit Warning Amid Revenue DeclinePremiumCompany Announcements
Tianda Pharmaceuticals Schedules Board Meeting to Approve Year-End Results0455 FAQ
What was Tianda Pharmaceuticals Ltd.’s price range in the past 12 months?
Tianda Pharmaceuticals Ltd. lowest stock price was HK$0.07 and its highest was HK$0.27 in the past 12 months.
What is Tianda Pharmaceuticals Ltd.’s market cap?
Tianda Pharmaceuticals Ltd.’s market cap is HK$374.11M.
When is Tianda Pharmaceuticals Ltd.’s upcoming earnings report date?
Tianda Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 28, 2025 which is in 132 days.
How were Tianda Pharmaceuticals Ltd.’s earnings last quarter?
Tianda Pharmaceuticals Ltd. released its earnings results on Mar 28, 2025. The company reported -HK$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.016.
Is Tianda Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Tianda Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Tianda Pharmaceuticals Ltd. pay dividends?
Tianda Pharmaceuticals Ltd. pays a Annually dividend of HK$0.002 which represents an annual dividend yield of 2.99%. See more information on Tianda Pharmaceuticals Ltd. dividends here
What is Tianda Pharmaceuticals Ltd.’s EPS estimate?
Tianda Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianda Pharmaceuticals Ltd. have?
Tianda Pharmaceuticals Ltd. has 2,150,041,700 shares outstanding.
What happened to Tianda Pharmaceuticals Ltd.’s price movement after its last earnings report?
Tianda Pharmaceuticals Ltd. reported an EPS of -HK$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Tianda Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in HK:0455
Company Description
Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Technical Analysis
Wai Yuen Tong Medicine Holdings Limited
―
China NT Pharma Group Co., Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H
―
Huakang Biomedical Holdings Company Limited
―